Danaher Corporation $DHR Shares Sold by Mission Wealth Management LP

Mission Wealth Management LP cut its stake in shares of Danaher Corporation (NYSE:DHR) by 2.0% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 12,830 shares of the conglomerate’s stock after selling 266 shares during the period. Mission Wealth Management LP’s holdings in Danaher were worth $2,534,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in DHR. Boyd Watterson Asset Management LLC OH lifted its stake in Danaher by 2.1% in the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after acquiring an additional 51 shares during the last quarter. Worth Financial Advisory Group LLC raised its holdings in shares of Danaher by 4.6% in the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after purchasing an additional 53 shares in the last quarter. 1834 Investment Advisors Co. lifted its position in shares of Danaher by 3.3% during the 1st quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 54 shares during the last quarter. Bruce G. Allen Investments LLC grew its stake in shares of Danaher by 13.1% during the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock worth $92,000 after purchasing an additional 54 shares in the last quarter. Finally, Cassaday & Co Wealth Management LLC grew its stake in shares of Danaher by 1.2% during the first quarter. Cassaday & Co Wealth Management LLC now owns 4,717 shares of the conglomerate’s stock worth $967,000 after purchasing an additional 56 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Up 0.3%

DHR opened at $215.63 on Monday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The business’s 50 day moving average is $203.41 and its two-hundred day moving average is $199.60. The firm has a market cap of $152.31 billion, a price-to-earnings ratio of 44.46, a price-to-earnings-growth ratio of 3.28 and a beta of 0.77.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same period last year, the firm posted $1.71 earnings per share. The company’s revenue for the quarter was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s dividend payout ratio is presently 26.39%.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Robert W. Baird set a $247.00 price target on Danaher in a research note on Wednesday, October 22nd. Bank of America cut their target price on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research report on Monday, September 22nd. Barclays upped their price target on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. JPMorgan Chase & Co. increased their price target on shares of Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.